For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on April 9th, 2025 | 07:10 CEST
TAKEOVER and BUY RECOMMENDATION! Deutz, TUI, and 123fahrschule - Over 200% upside potential!
Analysts see upside potential of over 200% for the 123fahrschule share. With a digital business model, the Company is currently disrupting a traditional industry. After moving into the profit zone in 2024, earnings are now expected to rise sharply. In addition, the Company's business focus on Germany sets it apart positively from the geopolitical issues. The situation is different for TUI. Analysts are concerned that deglobalization could have a noticeable negative impact on the tourism group's business. In contrast, Deutz is benefiting from rising defense spending. The Cologne-based company is not resting on its laurels but is strengthening its e-mobility business through an acquisition. The new technology is also to be used in the military sector in the future.
Read
Commented by Fabian Lorenz on April 8th, 2025 | 07:00 CEST
Winners in the tariff quake: Renk, Nel ASA, Almonty – China attacks US defense industry
The tariff quake on the stock markets continued yesterday. For companies like Nike and the German automotive industry, the extent of the consequences is still unclear. However, there may also be winners. Tungsten producer Almonty emphasized yesterday that its defense-critical raw material is exempt from tariffs. In addition, China is tightening its controls on the export of critical raw materials. This makes Almonty shares even more attractive. Is a NASDAQ listing the next surprise? The effects of the tariffs are also likely to be manageable for RENK. The transmission manufacturer for tanks and other military vehicles has excellent business prospects here in Europe. The share was again recommended as a "Buy". Hydrogen could also benefit, as it helps diversify Europe's energy supply. Can Nel ASA benefit from this? A study shows that more investment in electrolysis capacity is needed in Europe.
Read
Commented by Fabian Lorenz on April 7th, 2025 | 07:30 CEST
100% price opportunity or short attack? Deutz, Bayer, Power Metallic Mines
Tension is rising at Deutz! While analysts are significantly raising their target price, short sellers are getting into position. Is it worth getting back in now? After all, the share price has corrected significantly. An interesting entry opportunity currently seems to be emerging at Power Metallic Mines. Under the name Power Nickel, the Company made headlines in 2024. Drilling uncovered not only massive nickel deposits but much more - and this is said to be just the beginning. The current price decline is an opportunity. In contrast, Bayer is simply unable to escape the negative headlines. The legal disputes will likely last at least until 2026. Nevertheless, analysts recommend buying the stock.
Read
Commented by Fabian Lorenz on April 7th, 2025 | 07:10 CEST
New gold rocket ahead of takeover? Tocvan Ventures stock on the heels of Barrick Gold & Co.
While Donald Trump escalates the tariff war, gold continues to shine with ever-higher prices. Even Friday's correction is unlikely to change that. An ounce of gold is trading solidly above USD 3,000 – and rising. This puts gold explorers back in the spotlight for investors. A lesser-known player could become a real gold rocket in 2025: Tocvan Ventures. Its project in Mexico is at an advanced stage and is to be developed into a world-class operation. High-grade deposits have recently been reported again, which could significantly increase the gold resource. In addition, a pilot mine is to be launched in 2025, which could make the Company a takeover candidate. The stock has jumped and still has plenty of room to run higher, especially compared to peers. Currently, this represents an exciting buying opportunity.
Read
Commented by Fabian Lorenz on April 4th, 2025 | 08:45 CEST
A bombshell for NetraMark shares: Is this the breakthrough for the AI biotech hidden gem?
Big news for NetraMark! The Company aims to revolutionize the clinical trial process for pharmaceutical and biotech companies - improving time efficiency, reducing costs, and increasing success rates. The software company has developed its own artificial intelligence for this purpose. Yesterday, NetraMark entered into a global partnership with a leading contract research organization (CRO). The partner is active in more than 60 countries with over 3,500 employees, and plans to use NetraMark's AI in its studies in the future. This could be the breakthrough for the AI specialist, potentially ending the stock's consolidation phase. With a market capitalization of less than CAD 100 million, the stock could have significant upside potential.
Read
Commented by Fabian Lorenz on April 3rd, 2025 | 07:20 CEST
Stock set for 100% rally! Evotec, thyssenkrupp, Vidac Pharma - A golden April ahead?
Can shareholders look forward to a 100% price gain soon? If analysts have their way, this could be imminent for Evotec. However, shareholders must first mark an important date in April, as the medium-term share price performance is likely to be decided then. For Vidac Pharma, analysts see even greater upside potential, making the current price weakness an interesting entry opportunity. After all, the biotech company is making operational progress. One of the surprises of the current week is thyssenkrupp. The Company is benefiting from billions being spent in defense and infrastructure. Now, it could also benefit from Trump's tariff policies. Analysts recommend buying.
Read
Commented by Fabian Lorenz on April 1st, 2025 | 07:10 CEST
Over 200% upside potential and a revenue surprise? Steyr Motors, D-Wave, and naoo shares
The current stock market phase is not for the faint-hearted. The price fluctuations of shares such as Steyr Motors, D-Wave, and social media newcomer naoo are severe. However, the latest price fluctuations also offer opportunities. Analysts see more than 200% upside potential in the Swiss technology company naoo. Driven by acquisitions, revenue and earnings are expected to rise sharply. D-Wave could surprise on the revenue side, as experts anticipate positive momentum from its latest partnership. And what is Steyr Motors doing? After the recent price fluctuations, BaFin may investigate. Major shareholder Mutares is also under scrutiny.
Read
Commented by Fabian Lorenz on March 31st, 2025 | 07:20 CEST
300% price rocket or hydrogen high flyer! Renk, Nel ASA, and dynaCERT
Another 30% upside with Renk shares? Analysts believe the defense company has room to grow. However, they are largely alone in this view, and the share price has already performed well. The situation is different for dynaCERT. The cleantech company is recommended as a "Buy" with 300% upside potential. With a German top management team, revenue is expected to multiply in the coming years, making the stock look like a bargain at current levels. Meanwhile, the Nel share appears cheap on the surface. However, the euphoria over Samsung's entry was short-lived, and a potential military order has failed to spark momentum. Was the market reaction justified?
Read
Commented by Fabian Lorenz on March 27th, 2025 | 07:00 CET
Rocketing prices and takeover speculation! Steyr Motors, Evotec, and Defence Therapeutics!
Steyr Motors is now riding not only the defense wave but also the takeover wave. After the announcement of a cooperation with a Rheinmetall subsidiary, the niche stock has become a shooting star. However, the price has also come back just as quickly. The Austrians now want to grow aggressively through acquisitions. Without takeover speculation, the share price of Defence Therapeutics has already risen by over 60%. The biotech company is still inexpensive, is making progress in monetization, and could become an acquisition candidate. Evotec is currently out of steam. Analysts see significant downside potential and a chance of a turnaround.
Read
Commented by Fabian Lorenz on March 26th, 2025 | 07:00 CET
ARMAMENTS and GOLD! Target prices are rising! Barrick Gold, Deutz, and Globex Mining!
The "Rambo Zambo" billions of Friedrich Merz continue to drive the Deutz share higher. After the solid annual figures, profit-taking seemed likely to set in for the engine manufacturer's shares, but this was misinterpreted! Yesterday, analysts again raised the target price significantly! The Globex Mining share is also performing strongly. The mining incubator is benefiting not only from the rising gold price, which remains solidly above the USD 3,000 mark. Will it crack the USD 3,500 mark soon? A deal has now been brokered with IAMGOLD. And what is Barrick Gold doing? After the recovery rally, it seems momentum has slowed. Now, a project is also being abandoned.
Read